PharmTech Europe News

AstraZeneca Progresses Rollout of COVID-19 Vaccine to Low- and Middle-Income Countries

March 03, 2021

AstraZeneca has announced that the mass rollout of its COVID-19 vaccine has begun via the COVAX initiative.

Oxular Completes Financing Round Worth $37 million

March 03, 2021

Oxular has raised US $37 million in a financing round led by specialist life sciences investor, Forbion.

Arcline Investment Management Acquires ChargePoint Technology

March 03, 2021

Arcline Investment Management has acquired ChargePoint Technology, strengthening its global presence.

Survey Demonstrates Upswing in Swedish Life Sciences Growth

March 03, 2021

A recent survey by SwedenBIO has demonstrated a major upswing in the Swedish life science industry.

EMA Recommends Oral Treatment for SMA

March 03, 2021

EMA has recommended that Evrysdi be granted marketing authorization in the EU for the treatment of patients with certain types of SMA.

Slovakia Approves Sputnik V Vaccine

March 03, 2021

RDIF has announced that the Sputnik V vaccine for COVID-19 has been approved in Slovakia under the emergency use authorization procedure.

EC Launches Structured Dialogue to Address Medicines Supply Vulnerabilities

March 03, 2021

The EC has launched a structured dialogue aimed at gaining a better understanding of global medicines supply chains and to identify potential causes and drivers of vulnerabilities.

EMA Commences Rolling Review of Regdanvimab

February 26, 2021

EMA's CHMP has started a rolling review of regdanvimab (CT-P59), which is a monoclonal antibody being developed by Celltrion for the treatment of COVID-19.

NICE Recommends TheraSphere as Treatment for HCC

February 26, 2021

NICE has issued guidance recommending the use of TheraSphere Y-90 Glass Microspheres, from Boston Scientific, as a treatment for patients with HCC.

Quotient Sciences Acquires CDMO Arcinova

February 17, 2021

The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.